LEUNG; Yun Chung

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEUNG; Yun Chung.The latest application filed is for "method of treating aml subtypes using arginine-depleting agents".

Company Profile

1.12.15

LEUNG; Yun Chung - Hong Kong CN
LEUNG; Yun Chung - Shatin N.T.
Leung; Yun Chung - Kowloon HK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treating AML subtypes using arginine-depleting agents App 20210401952 - KWOK; Sui-Yi ; et al.	2021-12-30
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein Grant RE48,805 - Wong , et al. November 2, 2	2021-11-02
Compositions And Methods For Amino Acid Depletion Therapy App 20210189370 - LAU; Johnson Yiu-Nam ; et al.	2021-06-24
Methods for Inducing Intermittent Fasting and Modulating Autophagy App 20210162028 - LEUNG; Yun Chung ; et al.	2021-06-03
Composition and Application of Arginine-depleting Agents for Cancer, Obesity, Metabolic Disorders, and Related Complications and App 20200181597 - LEUNG; Yun Chung ; et al.	2020-06-11
Albumin-binding arginine deiminase and the use thereof Grant RE47,233 - Wong , et al. Feb	2019-02-12
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein Grant 9,803,185 - Wong , et al. October 31, 2	2017-10-31
Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents Grant 9,382,525 - Leung , et al. July 5, 2	2016-07-05
Albumin-binding Arginine Deiminase For Cancer Targeting Treatment And Detection Of Arginine App 20160115468 - Wong; Bing Lou ; et al.	2016-04-28
Albumin-binding arginine deminase and the use thereof Grant 9,255,262 - Wong , et al. February 9, 2	2016-02-09
Pharmaceutical Composition Comprising Albumin-binding Arginine Deiminase For Cancer Targeting Treatment App 20140255377 - WONG; Bing Lou ; et al.	2014-09-11
Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation Grant 8,679,810 - Cheng , et al. March 25, 2	2014-03-25
Site-directed Pegylation Of Arginases And The Use Thereof As Anti-cancer And Anti-viral Agents App 20140023628 - LEUNG; Yun Chung ; et al.	2014-01-23
Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents Grant 8,507,245 - Leung , et al. August 13, 2	2013-08-13
Method and system for detection of chloramphenicol Grant 8,329,425 - Wong , et al. December 11, 2	2012-12-11
Method and System for Detection of Chloramphenicol App 20120219978 - Wong; Kwok Yin ; et al.	2012-08-30
Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation Grant 7,951,366 - Cheng , et al. May 31, 2	2011-05-31
Site-directed Pegylation Of Arginases And The Use Thereof As Anti-cancer And Anti-viral Agents App 20100247508 - Leung; Yun Chung ; et al.	2010-09-30
Method for production of alpha-amylase in recombinant Bacillus Grant 7,550,281 - Leung , et al. June 23, 2	2009-06-23
Pharmaceutical Preparation And Method Of Treatment Of Human Malignancies With Arginine Deprivation App 20090123450 - Cheng; Ning Man ; et al.	2009-05-14
Use of Arginase in Combination with 5FU and Other Compounds for Treatment of Human Malignancies App 20080292609 - Cheng; Ning Man ; et al.	2008-11-27
Pharmaceutical Preparation And Method Of Treatment Of Human Malignancies With Arginine Deprivation App 20080248018 - Cheng; Ning Man ; et al.	2008-10-09
Pharmaceutical Preparation and Method of Treatment of Human Malignancies with Arginine Deprivation App 20080226617 - Cheng; Ning Man ; et al.	2008-09-18
Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation App 20050244398 - Cheng, Ning Man ; et al.	2005-11-03
Method for production of alpha-amylase in recombinant bacillus App 20020187541 - Leung, Yun Chung ; et al.	2002-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.